VASCULAR PHARMACEUTICALS

Company Information
Address 1088 KNOLLRIDGE RD
BURLINGTON, NC, 27217-


Information

DUNS: 601953974

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Development of a novel method for inhibiting diabetic retinopathy

    Amount: $172,913.00

    DESCRIPTION (provided by applicant): The long-term objective of the proposed study is to develop a monoclonal antibody that inhibits the progression of diabetic retinopathy. Insulin-like growth factor ...

    STTRPhase I2012Department of Health and Human Services
  2. Development of a Novel Method for Inhibiting Atherosclerosis in Diabetes

    Amount: $1,218,280.00

    DESCRIPTION (provided by applicant): The long term objective of the proposed studies is to develop a monoclonal antibody that can be administered safely to patients with diabetes that will inhibit ath ...

    STTRPhase II2009Department of Health and Human Services
  3. Development of a Novel Method for Inhibiting Atherosclerosis in Diabetes

    Amount: $210,260.00

    DESCRIPTION (provided by applicant): The long term objective of the proposed studies is to develop a monoclonal antibody that can be administered safely to patients with diabetes to determine if it ca ...

    STTRPhase I2006Department of Health and Human Services
  4. Development of a Novel Method for Inhibiting Atherosclerosis in Diabetes

    Amount: $210,260.00

    DESCRIPTION (provided by applicant): The long term objective of the proposed studies is to develop a monoclonal antibody that can be administered safely to patients with diabetes to determine if it ca ...

    SBIRPhase IDepartment of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government